| scholarly article | Q13442814 |
| P2093 | author name string | Nowicki R | |
| Sonesson A | |||
| Barańska-Rybak W | |||
| Schmidtchen A | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 260-265 | |
| P577 | publication date | 2005-12-30 | |
| P1433 | published in | Journal of Antimicrobial Chemotherapy | Q6294770 |
| P1476 | title | Glycosaminoglycans inhibit the antibacterial activity of LL-37 in biological fluids | |
| P478 | volume | 57 |
| Q35783119 | 2-O-Sulfated Domains in Syndecan-1 Heparan Sulfate Inhibit Neutrophil Cathelicidin and Promote Staphylococcus aureus Corneal Infection |
| Q34980992 | A small peptide with therapeutic potential for inflammatory acne vulgaris |
| Q89959145 | Anionic food color tartrazine enhances antibacterial efficacy of histatin-derived peptide DHVAR4 by fine-tuning its membrane activity |
| Q40341558 | Antibacterial Defense of Human Airway Epithelial Cells from Chronic Obstructive Pulmonary Disease Patients Induced by Acute Exposure to Nontypeable Haemophilus influenzae: Modulation by Cigarette Smoke. |
| Q39338332 | Antifungal Resistance, Metabolic Routes as Drug Targets, and New Antifungal Agents: An Overview about Endemic Dimorphic Fungi. |
| Q38447222 | Antifungal activities of peptides derived from domain 5 of high-molecular-weight kininogen |
| Q37383388 | Antimicrobial activity of Tachyplesin 1 against Burkholderia pseudomallei: an in vitro and in silico approach. |
| Q24310093 | Antimicrobial activity of neuropeptides against a range of micro-organisms from skin, oral, respiratory and gastrointestinal tract sites |
| Q36920921 | Bacterial strategies of resistance to antimicrobial peptides. |
| Q42021694 | Candida albicans mucin Msb2 is a broad-range protectant against antimicrobial peptides. |
| Q36055572 | Candidacidal Activity of Selected Ceragenins and Human Cathelicidin LL-37 in Experimental Settings Mimicking Infection Sites. |
| Q37127416 | Cathelicidin antimicrobial peptides inhibit hyaluronan-induced cytokine release and modulate chronic allergic dermatitis |
| Q28395363 | Cationic antimicrobial peptide LL-37 is effective against both extra- and intracellular Staphylococcus aureus |
| Q35963490 | Cationic antimicrobial peptide resistance mechanisms of streptococcal pathogens |
| Q57349427 | Chitosan composites for biomedical applications: status, challenges and perspectives |
| Q57021966 | Copper regulates the interactions of antimicrobial piscidin peptides from fish mast cells with formyl peptide receptors and heparin |
| Q37784318 | Diverse functions of glycosaminoglycans in infectious diseases. |
| Q34058642 | Evaluation of the ability of LL-37 to neutralise LPS in vitro and ex vivo. |
| Q92256576 | Expression and Function of Host Defense Peptides at Inflammation Sites |
| Q33870762 | Formulation and candidacidal activity of magnetic nanoparticles coated with cathelicidin LL-37 and ceragenin CSA-13. |
| Q38095685 | Glycosaminoglycans in infectious disease |
| Q58914917 | Hypertonic saline in treatment of pulmonary disease in cystic fibrosis |
| Q38617909 | Identification of bacterial biofilm and the Staphylococcus aureus derived protease, staphopain, on the skin surface of patients with atopic dermatitis |
| Q55325660 | Immunomodulation and effects on microbiota after in ovo administration of chicken cathelicidin-2. |
| Q41380267 | LPS modification promotes maintenance of Yersinia pestis in fleas |
| Q30484999 | Magainin 2 in action: distinct modes of membrane permeabilization in living bacterial and mammalian cells |
| Q42220551 | Modulation of exogenous antibiotic activity by host cathelicidin LL-37. |
| Q40812978 | Msb2 shedding protects Candida albicans against antimicrobial peptides |
| Q35329635 | Neutrophil antimicrobial defense against Staphylococcus aureus is mediated by phagolysosomal but not extracellular trap-associated cathelicidin |
| Q28742923 | Novel sulfated polysaccharides disrupt cathelicidins, inhibit RAGE and reduce cutaneous inflammation in a mouse model of rosacea |
| Q41907587 | Potential of host defense peptide prodrugs as neutrophil elastase-dependent anti-infective agents for cystic fibrosis. |
| Q40075939 | Preventive effects of the novel antimicrobial peptide Nal-P-113 in a rat Periodontitis model by limiting the growth of Porphyromonas gingivalis and modulating IL-1β and TNF-α production |
| Q36018223 | Pseudomonas aeruginosa elastase cleaves a C-terminal peptide from human thrombin that inhibits host inflammatory responses |
| Q36220338 | Role of glycosaminoglycans in infectious disease |
| Q36977156 | The Human Cathelicidin Antimicrobial Peptide LL-37 as a Potential Treatment for Polymicrobial Infected Wounds |
| Q33467561 | The anticancer activity of lytic peptides is inhibited by heparan sulfate on the surface of the tumor cells |
| Q43878141 | Thymic stromal lymphopoietin exerts antimicrobial activities |
Search more.